
International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
WSMCDD-2025
GSMCDD-2025
Conferences Published ↓
RBS:RH-COVID-19 (2023)
ICMRS'23
PIPRDA-2023
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 7 Issue 2
March-April 2025
Indexing Partners



















Role of Insect-Derived Antimicrobial Peptides in Overcoming Multidrug-Resistant Infections
Author(s) | Dr. Priti Saxena |
---|---|
Country | India |
Abstract | The rise of antibiotic resistance has emerged as a critical global health threat, necessitating the urgent development of novel antimicrobial agents. Insect-derived antimicrobial peptides (AMPs) offer a promising alternative to conventional antibiotics due to their broad-spectrum activity, rapid bactericidal mechanisms, and reduced likelihood of inducing resistance. Insects, which constitute the largest and most diverse group of organisms, have evolved a sophisticated innate immune system that produces AMPs to counteract microbial infections. These peptides exhibit diverse structures and mechanisms of action, including membrane disruption, inhibition of intracellular targets, and modulation of immune responses. Notable insect AMPs, such as defensins, cecropins, and drosocins, have demonstrated potent activity against multidrug-resistant (MDR) bacterial strains, including Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli. This review explores the potential of insect-derived AMPs as next-generation therapeutics to combat antibiotic resistance. It examines their structural diversity, mechanisms of action, and efficacy against MDR pathogens. Furthermore, it discusses the challenges associated with their clinical application, including stability, toxicity, and large-scale production, along with recent advancements in synthetic modifications and nanotechnology-based delivery systems. By harnessing the antimicrobial potential of insect AMPs, researchers can develop innovative strategies to address the growing crisis of antibiotic resistance. This study highlights the necessity of integrating insect-derived AMPs into the antibiotic pipeline and emphasizes their role as a viable solution for the post-antibiotic era. |
Keywords | Insect antimicrobial peptides, antibiotic resistance, multidrug-resistant bacteria, innate immunity, therapeutic peptides, alternative antibiotics, AMPs |
Field | Biology > Zoology |
Published In | Volume 7, Issue 2, March-April 2025 |
Published On | 2025-04-18 |
DOI | https://doi.org/10.36948/ijfmr.2025.v07i02.41583 |
Short DOI | https://doi.org/g9f4sm |
Share this

E-ISSN 2582-2160

CrossRef DOI is assigned to each research paper published in our journal.
IJFMR DOI prefix is
10.36948/ijfmr
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.
